Unichem Laboratories Limited
Polunin Emerging Markets Small Cap Fund bought 6,00,901 shares of Unichem Laboratories for ₹38.84 Cr at ₹646.44 apiece in a bulk deal.
A pharmaceutical company engaged in the manufacture and distribution of generic medicines, active pharmaceutical ingredients, and contract manufacturing services across multiple therapeutic areas. Unichem Labs operates through an integrated manufacturing infrastructure, serving both domestic and international markets. The company distinguishes itself by offering affordable healthcare solutions while maintaining rigorous quality standards across its diverse product portfolio and manufacturing operations.
An institutional long-only emerging-markets small-cap fund managed by London-based Polunin Capital Partners. The strategy launched in 2007 and uses a valuation-driven, contrarian process to find mispriced cyclical businesses. Polunin manages about £5.8 billion across five funds and separately managed accounts.